Rhythms in human bone marrow and blood cells

Chronobiology International

Volumn 19, Issue 1, 2002, Pages 101-127

  Smaaland, Rune ^a   Sothern, Robert B ^b   Laerum, Ole D ^a   Abrahamsen, Jenny Foss ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Biological rhythm; Blood; Bone marrow; CD34+ cells; Colony forming units granulocyte macrophage; DNA; Glutathione; Hematopoiesis; Leukocytes; S phase

Indexed keywords

ARTICLE; BIOLOGICAL RHYTHM; BLOOD CELL; BONE MARROW CELL; CELL CYCLE S PHASE; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CIRCADIAN RHYTHM; COLONY FORMING UNIT; DNA SYNTHESIS; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKOCYTE; STEM CELL;

ANTINEOPLASTIC AGENTS; BLOOD CELLS; BONE MARROW; BONE MARROW CELLS; CELL CYCLE; CELL DIFFERENTIATION; CHRONOTHERAPY; CIRCADIAN RHYTHM; COLONY-FORMING UNITS ASSAY; DNA; ERYTHROPOIESIS; GLUTATHIONE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; NEOPLASMS; SEASONS;

EID: 0036229016     PISSN: 07420528     EISSN: None     Source Type: Journal    
DOI: 10.1081/CBI-120002594     Document Type: Article

References (88)

1. Circadian rhythm of cellular proliferation in the human rectal mucosa
2. The diumal mitotic rhythm in the human epidermis
3. Mitotic activity in the human epidermis
4. Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: Intrinsic differences and cell cycle effects
5. Recombinant GM-CSF in myelosuppression of chemotherapy
6. Clinical pharmacodynamics of anticancer drugs: Basis for extending the concept of dose-intensity
7. A randomized phase II multicenter trial of Irinotecan (CPT-11) using different schedules in patients with metastatic colorectal cancer
8. Applicarions of dose intensity to problems in chemotherapy of breast and colorectal cancer
9. Glutathione export by human lymphoid cells: Depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation
10. Increased melphalan activity in intracranial human medulloblstoma and glioma xenografts following buthionine sulfoximine-mediated gluthatione depletion
11. Depletion of tumor versus normal tissue glutathione by buthionine sulfoximine
12. Changes in intracellular GSH content during adriamycin treatment in human ovarian cancer - A possible indicator of chemosensitivity
13. Glutathione contents in human and rodent tumor cells in various phases of the cell cycle
14. Mortality of mice as influenced by the hour of day of drug (ara-C) administration
15. Increased tolerance of leukemic mice to arabinosyl cytosine with schedule adjusted to circadian system
16. Experimental chronotherapy with ara-C; Comparison of murine ara-C tolerance on differently timed treatment schedules
17. Close reproduction by different laboratories of characteristics of circadian rhythms in 1-β-D-arabinofuranosylcytosine tolerance by mice
18. Combined chronochemotherapy of L1210 leukemic mice using 1-β-D-arabino-furanosylcytosine, cyclophosphamide, vincristine, methyl-prednisolone, and cis-platinum
19. Circadian timing of cancer chemotherapy
20. The myelotoxicity of carboplatin is influenced by the time of its administration
21. Maintenance chemotheraphy for childhood acute lymphoblastic leukemia: Better in the evening
22. Circadian time-dependent response of childhood lymphoblastic leukemia to chemo-therapy: A long-term follow-up study of survival
23. Methods for cosinor rhytmometry
24. DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients
25. The role of thiols in cellular response to radiation and drugs
26. The use of drugs which deplete intracellular glutathione in hypoxic cell radiosensitization
27. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
28. Enhancement of EMT6/SF tumor cell killing by mitomycin C and cyclophosphamide following in vivo administration of buthionine sulfoximine
29. Chemosenzitation by buthionine sulfoximine in vivo
30. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells
31. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion
32. Glutathione content in human bone marrow and circadian stage relation to DNA synthesis
33. Daily variation in non-protein sulfhydryl levels of human bone marrow
34. Characterization of a Cisdiaminedichloroplatinum (II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues
35. Elevation of intracellular glutathione content associated with mitogenic stimulation of quiescent fibroblasts
36. Steroid modulation of naturally occuring diural variations in circulating pluripotential haemotopoietic cells
37. Comparison between diural changes and changes induces by hydrocortisone and epinephrine in circulating myeloid progenitor cells (CFU - GM) in man
38. Diurnal variation of circulating human myeloid progenitor cells
39. Diurnal changes in circulating myeloid progenitor cells in man
40. Colony-forming units - Granulocyte/macrophage and DNA synthesis of human bone marrow are circadian stage-dependent and show covariation
41. Mitotic indices of human bone marrow cells. I. Number and cytologic distribution of mitosis
42. Diurnal variation of proliferative activity in the human bone marrow
43. Flow cytometric measurement of DNA S-phase in human bone marrow cells: Correcting for peripheral blood contamination
44. Flow cytometric assessment of peripheral blood contamination and proliferative activity of human bone marrow cell populations
45. Simultaneous measurement of DNA content and cell-surface immunofluorescence of human bone marrow cells using a single laser flow cytometer
46. Variation in cell yield and proliferative activity of positive selected human CD34+ bone marrow cells along the circadian time scale
47. Agreement of circadian chracteristics for total leukocyte counts in different geographic locations
48. Chronobiology in hematology and immunology
49. Reference values for circadian rhythms of 98 variables in clinically healthy men in fifth decade of life
50. Circadian/or circahemidian rhythms in nine lymphocyte related variables from peripheral blood of healthy subjects
51. Circadian phase relationships between peripheral blood variables and bone marrow proliferative activity in clinical health
52. Time of day versus internal circadian timing references
53. Circadian cell cycle variations of erythro- and myelopoiesis in man
54. DNA synthesis in human bone marrow in circadian stage dependent
55. Circadian variation in serum cortisol and circulating neutrophils are markers for circadian variation of bone marrow proliferation in cancer patients
56. Marker rhythms for cancer chronotherapy. From laboratory animals to human beings
57. Cortisol and hematologic circadian rhythms in patients with metastatic colorectal cancer
58. Circadian variations in human peripheral blood on days with and without bone marrow sampling and relation to bone marrow cell proliferation
59. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intra-patient variation depending on circadian stage of cell sampling
60. Über die 24-stunden-rhythmik der mitozfrequenz in malignen tumoren
61. Cell cycle phase specificity of antitumor agents
62. Effects of the L-isomer (+)-1,2-Bis(3,5-dioxopiperazine-lyl) propane on cell survival and cell progression of cultured mammalian cells
63. Effects of aclacinomycin on cell survival and cell cycle progression and survival of cultured mammalian cells
64. Circadian and seasonal changes in murine bone marrow colony forming cells affect tolerance for 4′tetrahydropyranyladriamycin
65. Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide
66. Circadian characteristics of circulating interleukin-6 in men
67. Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-L, and granulocyte-macrophage colony- stimulating factor in men
68. Evidence for a beta-adrenergic receptor initiating DNA synthesis in hemopoietic stem cells
69. T-helper-2 lymphocytes as a peripheral target of melatonin
70. Effect of the pineal gland on circadian rhythmicity of colony forming units for granulocytes and macrophages (CFU - GM) from rat bone marrow cell cultures